DUBLIN–(BUSINESS WIRE)–The “Lab-On-A-Chip Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030” report has been added to ResearchAndMarkets.com’s offering.
A lab-on-a-chip is a device that integrates one or more laboratory functions on a single integrated circuit or a chip to achieve automation and high-throughput screening. The application of lab-on-a-chip is increasing in different field of life sciences. From detecting breast cancer to screening for HIV, surviving serious disease, all of it is done with the help of a chip or a microarray.
LOC technology enables the use of small fluid volumes which helps cut costs and the analysis of reagents and response time. Several applications in life science and medicine have also been explored so far including potential use in protein crystallization studies and DNA or RNA sequencing.
The applications student in the global lab-on-a-chip market include genomics & proteomics, diagnostics, drug discovery and others. The diagnostics segment held the largest share in the global lab-on-a-chip market by application. Early screening of breast cancer, HIV and other infectious diseases is driving the market for diagnostics segment. Genomics and proteomics are expected to grow at the highest rate due to rising research and development studies in genetic and sequencing to drive the market in the future.
In the year 2021, North America emerged as the largest regional market for lab-on-a-chip market. The highest market share of the region is attributed to existence of evolved healthcare and biotechnology research infrastructure, availability of microarray chips in an affordable cost in the region encouraging the diagnostic applications. Favorable private and public funding in research and development in the U.S. makes it highest grossing country in North America. Asia Pacific is anticipated to be the fastest growing lab-on-a-chip market during the forecast period. Rapid entry of market leaders in the region, unmet medical needs, rising incidences of various infectious disease would further craft as a growth factor for the growth of Asia-Pacific lab-on-a-chip market. The competitors in the Asia Pacific market are budding and are continually working on introducing new clinical uses to augment value of lab-on-a-chip technology.
Market Segmentation
Product
DNA Microarrays
Lab on a chip/Microfluidics
Protein Microarrays
Tissue Biochips
Carbohydrate Biochips
Application
Genomics & Proteomics
Diagnostics
Drug Discovery
Others
Key Questions Answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Lab-On-A-Chip market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2030.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Lab-On-A-Chip market?
Which is the largest regional market for Lab-On-A-Chip market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Lab-On-A-Chip market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Lab-On-A-Chip market worldwide?
Key Topics Covered:
1. Preface
2. Executive Summary
3. Lab-On-A-Chip Market: Business Outlook & Market Dynamics
4. Lab-On-A-Chip Market: By Product, 2020-2030, USD (Million)
5. Lab-On-A-Chip Market: By Application, 2020-2030, USD (Million)
6. North America Lab-On-A-Chip Market, 2020-2030, USD (Million)
7. UK and European Union Lab-On-A-Chip Market, 2020-2030, USD (Million)
8. Asia Pacific Lab-On-A-Chip Market, 2020-2030, USD (Million)
9. Latin America Lab-On-A-Chip Market, 2020-2030, USD (Million)
10. Middle East and Africa Lab-On-A-Chip Market, 2020-2030, USD (Million)
11. Company Profile
Companies Mentioned
Agilent Technologies Inc.
Danaher Corporation
Becton
Dickinson and Company
Bio-Rad Laboratories
Abbott Laboratories
F. Hoffmann-La Roche AG
Perkinelmer Inc.
IDEX Corporation
Thermo Fisher Scientific Inc.
RainDance Technologies Inc.
Fluidigm Corporation.
For more information about this report visit https://www.researchandmarkets.com/r/993275
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
